In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1813 News Items found
The co-leaders of the MSK Lobular Breast Cancer program are seen together.
What Is Invasive Lobular Carcinoma? MSK Doctors Explain

Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.
Dr. Nancy Lee, Dr. Alan Ho, and Dr. Richard Wong review scans on a computer
ASTRO 2025 Highlights From MSK

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.
Chrysothemis Brown
Immunologist Chrysothemis Brown Named a 2025 Howard Hughes Medical Institute Freeman Hrabowski Scholar

Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.
Clinical Update
MSK radiation oncologist Dr. Nancy Lee.
Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery

Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma.
Lab member using a next-generation sequencing machine
To Study Treatment Resistance in High-Grade Serous Ovarian Cancer, MSK Researchers Develop New Approach

An MSK research team aims to find new ways to stop the most common and deadly form of ovarian cancer — high-grade serous ovarian cancer — from recurring with the help of a method they developed for tracking the evolution of treatment resistant cells in ovarian cancer using blood tests.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
Article
MSK medical oncologist Komal Jhaveri.
FDA Approves Imlunestrant to Stop Progression of ER+, HER2-, ESR1-mutated Advanced Breast Cancer That Resists Standard Therapy

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.
A researcher working in an MSK lab
MSK Research Highlights, September 25, 2025

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.
Feature
Dr. Miguel-Angel Perales
Reasons Why MSK Is a Leader in Stem Cell and Bone Marrow Transplants

Dr. Miguel-Angel Perales explains why MSK has continued to be a leader in the field of stem cell and bone marrow transplantation for more than 50 years.
Gloved hands hold several test tubes of blood with a piece of lab equipment in the background
Liquid Biopsies and Other Blood Tests for Cancer: What You Should Know 

Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.